4.1 Article

Healthcare utilization and direct medical costs of Huntington's disease among Medicaid beneficiaries in the United States

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study

Idaira Rodriguez-Santana et al.

Summary: This study estimates the economic burden of Huntington disease (HD) by analyzing the direct medical, nonmedical, and indirect costs associated with HD based on the Huntington's Disease Burden of Illness (HDBOI) study. The results show that the economic burden for individuals with HD and their caregivers increases as the disease progresses.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Health Care Sciences & Services

Health care resource utilization and costs among individuals with vs without Huntington disease in a US population

Tu My To et al.

Journal of Managed Care & Specialty Pharmacy (2023)

Article Economics

Healthcare resource utilization and costs in individuals with Huntington's disease by disease stage in a US population

Alex Exuzides et al.

Summary: This study aimed to quantify healthcare resource utilization and costs by disease stage in individuals with Huntington's disease (HD) in a US population. The findings suggest that the burden of care is high among individuals with HD, particularly among those with middle- and late-stage disease.

JOURNAL OF MEDICAL ECONOMICS (2022)

Article Public, Environmental & Occupational Health

Epidemiology of Huntington's Disease in the United States Medicare and Medicaid Populations

Alex Exuzides et al.

Summary: This study examines the epidemiology of Huntington's disease (HD) in the United States (US) and suggests that the prevalence and incidence of HD may be higher than previously estimated. These findings emphasize the importance of raising awareness of HD among healthcare providers and payers, as well as ensuring the availability and access to services for HD patients and caregivers in the Medicare and Medicaid populations.

NEUROEPIDEMIOLOGY (2022)

Article Clinical Neurology

Neuropsychiatric comorbidities in Huntington's and Parkinson's Disease: A United States claims database analysis

Lianna Ishihara et al.

Summary: This study used United States claims data to compare prevalent comorbidities and medication use in individuals with Huntington's disease. Results showed that depression, anxiety, dementia, communication/speech problems, dysphagia, falls, as well as antidepressant and antipsychotic medication use were more common in Huntington's disease compared to Parkinson's disease. This highlights the need for holistic expert care for individuals with Huntington's disease.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Article Economics

Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States

Alex Exuzides et al.

Summary: This study examined healthcare utilization and costs in a US Medicare population diagnosed with Huntington's disease. The findings showed that individuals with HD have significantly higher healthcare needs and associated costs compared to those without HD.

JOURNAL OF MEDICAL ECONOMICS (2021)

Article Neurosciences

Current and projected future economic burden of Parkinson's disease in the U.S.

Wenya Yang et al.

NPJ PARKINSONS DISEASE (2020)

Article Health Care Sciences & Services

Medicare Cost at End of Life

Ian Duncan et al.

AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2019)

Article Health Care Sciences & Services

Utilization of Hospice Services in a Population of Patients With Huntington's Disease

Margaret O. Johnson et al.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2018)

Article Clinical Neurology

Hospitalizations of Children with Huntington's Disease in the United States

Adys Mendizabal et al.

MOVEMENT DISORDERS CLINICAL PRACTICE (2017)

Review Neurosciences

Neuropsychiatric Burden in Huntington's Disease

Ricardo Augusto Paoli et al.

BRAIN SCIENCES (2017)

Article Genetics & Heredity

The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease

Jae Whan Keum et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2016)

Article Clinical Neurology

The societal cost of Huntington's disease: are we underestimating the burden?

C. Jones et al.

EUROPEAN JOURNAL OF NEUROLOGY (2016)

Article Medicine, General & Internal

The direct medical costs of Huntington’s disease by stage. A retrospective commercial and Medicaid claims data analysis

Victoria Divino et al.

JOURNAL OF MEDICAL ECONOMICS (2013)

Review Clinical Neurology

The incidence and prevalence of Huntington's disease: A systematic review and meta-analysis

Tamara Pringsheim et al.

MOVEMENT DISORDERS (2012)

Review Clinical Neurology

Depression in the early stages of Huntington disease

Eric A. Epping et al.

NEURODEGENERATIVE DISEASE MANAGEMENT (2011)

Article Health Care Sciences & Services

All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States

Carl V. Asche et al.

JOURNAL OF MANAGED CARE PHARMACY (2010)

Meeting Abstract Clinical Neurology

EUROPEAN-HUNTINGTON'S DISEASE BURDEN STUDY (EURO-HDB) - PRELIMINARY RESULTS FOR ITALY AND FRANCE

J. Dorey et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)

Review Medicine, General & Internal

Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration

Jan P. Vandenbroucke et al.

PLOS MEDICINE (2007)

Article Clinical Neurology

No going home for hospitalized Huntington's disease patients

RM Dubinsky

MOVEMENT DISORDERS (2005)